Adamis Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Update

SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -.....»»

Pre-Commercial Launch Preparations Underway for AZEDRA® (iobenguane I 131) ahead of U.S. Food and Drug Administration (FDA) July 30th Action Date Top-Line Data from Phase 3 Trial .....»»

CASI Pharmaceuticals Announces Second Quarter And First Half 2018 Financial And Business Results - China FDA (CFDA) import drug re.....»»

VolitionRx Limited Announces Second Quarter 2018 Financial Results and Business Update PR Newswire ISNES, Belgium, Aug. 13, 2018 ISNES, Belgium, Aug. 13, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition") today announced financi.....»»

Enrollment continues in Phase 3 GBM brain cancer trial Key European patent validated covering oral formulation of TSC Preparing for Phase 2 stroke trial with in-am.....»»

Fennec Provides Business Update and Announces Second Quarter 2018 Financial Results.....»»

WALTHAM, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage, specialty pharmac.....»»

Intercept Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update.....»»

In the release issued under the same headline on May 10, 2018 by Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), please note that in the Consolidated Balance Sheets table, Cash and cash equi.....»»

Appointed Mike Mutchler as President and CEO Engaged Whittle Consulting for an Optimization Study on the Mara Rosa Gold Project Extended the maturity of gol.....»»

CASI Pharmaceuticals Announces First Quarter 2018 Financial And Business Results - Preparations for EVOMELA® commercial launch in Chin.....»»

Fennec Provides Business Update and Announces First Quarter 2018 Financial Results.....»»

WALTHAM, Mass., May 11, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or the "Company"), a clinical-stage, specialty pharmaceutical company wi.....»»

Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2018 Financial Results.....»»

Syndax Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides .....»»

WHITE PLAINS, N.Y., Aug. 20, 2018 (GLOBE NEWSWIRE) -- SPAR Group, Inc. (NASDAQ:SGRP), a leading supplier of retail merchandising, business technology and other marketin.....»»

Therapix Biosciences Reports Second Quarter 2018 Financial Results and Provides Business Update PR Newswire TEL AVIV, Israel, Aug. 20, 2018 TEL AVIV, Israel, Aug. 20.....»»

Opened three clinical trials in 2018 Trials in which complement dysregulation is the primary disease driver CAPSTONE, the Phase III trial in naïve paroxysmal nocturnal hemoglobinuria (PNH), in which patient treatment has commenced Phase II U.S. trial f.....»»

Alvopetro Announces Operational Update and Second Quarter Financial and Operating Results Canada NewsWire CALGARY, Aug. 15, 2018 CALGARY, Aug. 15, 2018 /CNW/ - Alvopetro Energy Ltd. (TSX-V:ALV) announces an operational up.....»»

MGT Capital Announces Second Quarter 2018 Financial Results Company Will Hold Investor Update Call at 8:30 AM EDT Today PR Newswire DURHAM, N.C., Aug. 15, 2018 DURHAM, N.C., Aug. 15, 2018 /PRNewswire/ --Â.....»»